Nano3D's technology and revenues continue to impress RBCC

As Rainbow Coral Corp. (OTCBB:RBCC) continues its due diligence on Nano3D Biosciences (n3D), it's not just the early-stage biotech firm's groundbreaking technology that has impressed RBCC—It's also n3D's revenues.

“We continue to be impressed by n3D in our due diligence and look forward to closing the transaction”

"Nano3D's revolutionary Bio-Assembler system is already being commercially produced and sold," said RBCC CEO Patrick Brown. "That's rare for an early-stage company like n3D, and it makes the company very attractive. It fits our model target in this space—early-stage and close to or already commercial.

"We continue to be impressed by n3D in our due diligence and look forward to closing the transaction," he added.

The Bio-Assembler system enables scientists to grow and study cells in a three-dimensional environment more easily than ever before, making research on stem cells and other tissues dramatically faster and more affordable.